XM无法为美国居民提供服务。

Chinese stocks struggle amid sluggish recovery and limited stimulus – Stock Market News



China’s stock market suffered a lot of pain in 2022, mainly due to the draconian zero-Covid policies imposed when foreign economies were up and running without any restrictions. This year started with high expectations as market participants forecasted strong recovery prospects following China’s permanent exit from Covid-19 curbs. However, as latest data suggests that the economy is losing steam, while monetary and fiscal stimulus remain below expectations, Chinese stocks seem to be under pressure.

Recovery hopes get shattered

In the beginning of 2023, the outlook for Chinese stocks turned from extremely pessimistic to cautiously bullish after the government finally announced its plans to scale back most of the tough Covid-19 restrictions. Moreover, the prolonged regulatory crackdown in the Chinese tech sector and the long-lasting trade wars between China and the US seemed to be waning, potentially allowing Chinese stocks to unlock their value.

Even though China’s much anticipated exit from zero-Covid policies coupled with increased stimulus initially put the domestic economy back on the rails, a series of downbeat data quickly raised concerns that the economy is struggling to find its footing. On that front, the Chinese PMIs due this Friday are expected to reflect more weakness, potentially dealing another blow to Chinese risky assets. The manufacturing sector is expected to contract for a third straight month and services are set to grow at their slowest pace in six months.

Besides that, China’s consumption and traveling figures during the dragon boat festival were lower than their pre-Covid levels, validating the recent slowdown in spending.

Insufficient stimulus

To counter the observed weakness and stimulate the economy, both the Chinese government and the People’s Bank of China rolled out accommodative policies. Their measures included tax breaks for manufacturers and minor interest rate cuts, but markets appear unconvinced on whether the magnitude of this stimulus will be sufficient to spur growth. Up until now, Chinese authorities have adopted a targeted aid package, which could be bolstered in the second half of the year if recession fears grow.

New trade wars in sight?

China managed to withstand the US trade wars in the 2017-2021 period, but Biden’s administration is trying to reshape the economic relationship between the two countries by launching a series of measures to stop China's chip industry from progressing. On Wednesday, news emerged that US officials are considering tightening exports of AI chips to China to reduce the country’s capacity and exposure to new technologies. Given that AI is the leading factor behind the latest market rally in the US, Chinese tech stocks could pay a heavy toll if these restrictions are applied.

Alibaba levels to watch

Taking a technical look at Alibaba, we can see that the stock exhibited a steep uptrend since November 2022, which was followed by a massive decline in 2023. In the short-term, the price has dived beneath both the 50- and 200-day simple moving averages (SMAs), further darkening the technical outlook.

In the negative scenario, the price could initially test the recent 2023 bottom of $78.00 before the attention shifts to last year’s low of $58.00.

Alternatively, bullish actions could propel the price towards the recent rejection region of $94.00 or higher to test the Match peak of $105.00.

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明